Patent · US Active

Pyrimidinyl-diazospiro compounds

US10010551B2 · kind B2 · utility

2Cited by
10References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 11, 2017
Grant dateJul 3, 2018
Priority date
Expiry dateJul 11, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to spiro deriviatives, to the use of said derivatives in treating diseases and conditions mediated by modulation of voltage-gated sodium channels, to compositions containing said derivatives and processes for their preparation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.